While AT1/NEP inhibitors, DPP-4 inhibitors, HMGR inhibitors, MR antagonists, or PPAR-gamma agonists were all found to significantly normalize pulmonary edema/lung congestion, this parameter was assessed in only 49/194 (25%) papers. This evidence concerns the gene NR3C2 and edema.